申请人:Kobayashi Yoshihiko
公开号:US20120165283A1
公开(公告)日:2012-06-28
This invention relates to novel aminoglycoside antibiotics, which have potent antimicrobial activity against bacteria, which induce infectious diseases, particularly MRSA, and has no significant nephrotoxicity, and process for producing them. More particularly, the present invention relates to compounds represented by formula (Ia) or their pharmacologically acceptable salts or solvates, or their diastereomer mixtures, antimicrobial agents comprising them, and a process for producing them.
这项发明涉及一种新型氨基糖苷类抗生素,对引起感染性疾病的细菌,特别是MRSA具有强效的抗菌活性,并且没有显著的肾毒性,并提供制备它们的方法。更具体地,本发明涉及由式(Ia)表示的化合物或其药理学上可接受的盐或溶剂合物,或其对映体混合物,包括它们的抗微生物剂以及制备它们的方法。